MSLN and familial pancreatic carcinoma: Accumulating evidence demonstrates that MSLN exhibits minimal expression in normal pancreatic tissues or adjacent non-malignant tissues, whereas it demonstrates robust expression in the majority of pancreatic cancer tissues, with this differential expression pattern being statistically significant.42